Literature DB >> 7005959

Recent developments in disease-modifying antirheumatic drugs.

I M Hunneyball.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7005959     DOI： 10.1007/978-3-0348-7108-2_4

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN： 0071-786X


× No keyword cloud information.
  6 in total

1.  Effect of gold salts, D-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats.

Authors:  A J Lewis; R P Carlson; J Chang; F DeLustro
Journal:  Agents Actions       Date:  1984-06

2.  Defective monocyte accessory function due to surface sulphydryl (SH) oxidation in rheumatoid arthritis.

Authors:  M J McKeown; N D Hall; J R Corvalan
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

3.  The absence of antibodies to type II collagen in established adjuvant arthritis in rats.

Authors:  F DeLustro; R P Carlson; L J Datko; B DeLustro; A J Lewis
Journal:  Agents Actions       Date:  1984-06

4.  The antiinflammatory activity of the immunomodulator Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid).

Authors:  S C Gilman; R P Carlson; J Chang; A J Lewis
Journal:  Agents Actions       Date:  1985-10

5.  A history of the term "DMARD".

Authors:  Jonas Kure Buer
Journal:  Inflammopharmacology       Date:  2015-05-23       Impact factor: 4.473

Review 6.  To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology.

Authors:  Jonas Kure Buer
Journal:  Inflammopharmacology       Date:  2017-02-13       Impact factor: 4.473
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.